OneOncology: NGS Testing Is Backbone of Personalized Treatments
OneOncology and Genentech presented data at a symposium that examined genomic profiling and biomarker testing patterns in community oncology centers.
Read More
Search Results for: lung cancer
What’s Next for Liquid Biopsy Tests?
Foresight Diagnostics CEO and CSO Jake Chabon gives an overview of what’s next for liquid biopsy testing, and how it will impact the continuum of care.
Read More
Thermo Fisher’s Oncomine Dx Receives FDA Premarket Approval
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic.
Read More
Community Oncologists Use Biomarker Testing Less Than Academic Clinicians
A recent report showed less than half of community oncologists used biomarker testing for lung cancer — compared to 73% of academic clinicians.
Read More
Precision Medicine Blood Test Can ID Those who Will Respond to FDA-Approved Treatment
New research has uncovered a precision medicine test to identify a patient subgroup of a rare blood disorder who are more likely to respond to treatment.
Read More